MENÜ
CH | CHF
CH | CHF
-
- Alle Zentrifugen
- Tischzentrifugen
- Standzentrifugen
- Gekühlte Zentrifugen
- Mikrozentrifugen
- Mehrzweckzentrifugen
- Hochgeschwindigkeitszentrifugen
- Ultrazentrifugen
- Concentrator
- IVD Produkte
- High-Speed and Ultracentrifuge Consumables
- Zentrifugenröhrchen
- Zentrifugenplatten
- Gerätemanagement
- Proben- und Informationsmanagement
-
- Alle Pipetten, Dispenser und automatischen Liquid-Handling-Systeme
- Mechanische Pipetten
- Elektronische Pipetten
- Mehrkanalpipetten
- Direktverdrängerpipetten & Dispenser
- Pipettenspitzen
- Flaschenaufsatzdispenser
- Pipettierhilfen
- Zubehör für Dispenser & Pipetten
- Automatisches Pipettieren
- Verbrauchsartikel für die Automation
- Zubehör für die Automation
- Services für Dispenser & Pipetten
Sorry, we couldn't find anything on our website containing your search term.
Sorry, we couldn't find anything on our website containing your search term.
Vaccine Research Discovered
Well thought-out tools for pharmaceutical and biotech laboratories
Read more
Read less
THE MOST NOVEL VACCINES
Nucleic acid vaccines
Nucleic acid vaccines are made up of mRNA or plasmid DNA encoding viral antigenic components to express specific proteins of a pathogen after injection. The technology of mRNA vaccines made its breakthrough with SARS-CoV-2. With dozens of new applications including HIV, cancer, shingles, flu, cardiovascular applications, or Zika, it is a very promising technology.
Nucleic acid vaccines are made up of mRNA or plasmid DNA encoding viral antigenic components to express specific proteins of a pathogen after injection. The technology of mRNA vaccines made its breakthrough with SARS-CoV-2. With dozens of new applications including HIV, cancer, shingles, flu, cardiovascular applications, or Zika, it is a very promising technology.
Mehr erfahren
➕ Multiple advantages such as exceptionally fast modifiability in response to mutations, high versatility, high safety, and a fast, cost-efficient, and scalable production in a cell-free system. Vaccines for multiple indications can be produced using the same process.
➖ During vaccination the mRNA must be delivered directly into cells, which requires specific injection devices, electroporation, or a carrier molecule. mRNA vaccines exhibit instability and require a cold chain
➖ During vaccination the mRNA must be delivered directly into cells, which requires specific injection devices, electroporation, or a carrier molecule. mRNA vaccines exhibit instability and require a cold chain
Mehr erfahren
BETTER MRNA VACCINE DEVELOPMENT
Mehr erfahren
*All products are for Research Use Only (RUO).
Mehr erfahren
Mehr erfahren